Long-Term Effect of Varenicline (Chantix®) in Four Ataxic Patients: Prolonged Symptomatic Benefit Following Drug Discontinuation

Theresa A. Zesiewicz; Kelly L. Sullivan; Amber M. Miller; L. E. Dempsey; Israt Jahan; L. Wecker

Long-Term Effect of Varenicline (Chantix®) in Four Ataxic Patients: Prolonged Symptomatic Benefit Following Drug Discontinuation

Theresa A. Zesiewicz, Kelly L. Sullivan, Amber M. Miller, L. E. Dempsey, Israt Jahan, L. Wecker

Biostatistics, Epidemiology & Environmental Health Sciences

University of South Florida

Research output: Contribution to book or proceeding › Chapter

Abstract

This conference abstract was published in the Proceedings of the World Congress on Parkinson’s Disease and Related Disorders .

Original language	American English
Title of host publication	Proceedings of the World Congress on Parkinson’s Disease and Related Disorders
State	Published - Dec 12 2009

Disciplines

Epidemiology
Public Health

Keywords

Ataxic patients
Chantix®
Drug discontinuation
Long-term effect
Prolonged symptomatic benefit
Varenicline

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@inbook{d288bd3c62134e9b8b6c1799b994eca4,

title = "Long-Term Effect of Varenicline (Chantix{\textregistered}) in Four Ataxic Patients: Prolonged Symptomatic Benefit Following Drug Discontinuation",

abstract = " This conference abstract was published in the Proceedings of the World Congress on Parkinson{\textquoteright}s Disease and Related Disorders .",

keywords = "Ataxic patients, Chantix{\textregistered}, Drug discontinuation, Long-term effect, Prolonged symptomatic benefit, Varenicline",

author = "Zesiewicz, {Theresa A.} and Sullivan, {Kelly L.} and Miller, {Amber M.} and Dempsey, {L. E.} and Israt Jahan and L. Wecker",

year = "2009",

month = dec,

day = "12",

language = "American English",

booktitle = "Proceedings of the World Congress on Parkinson{\textquoteright}s Disease and Related Disorders",

}

TY - CHAP

T1 - Long-Term Effect of Varenicline (Chantix®) in Four Ataxic Patients: Prolonged Symptomatic Benefit Following Drug Discontinuation

AU - Zesiewicz, Theresa A.

AU - Sullivan, Kelly L.

AU - Miller, Amber M.

AU - Dempsey, L. E.

AU - Jahan, Israt

AU - Wecker, L.

PY - 2009/12/12

Y1 - 2009/12/12

N2 - This conference abstract was published in the Proceedings of the World Congress on Parkinson’s Disease and Related Disorders .

AB - This conference abstract was published in the Proceedings of the World Congress on Parkinson’s Disease and Related Disorders .

KW - Ataxic patients

KW - Chantix®

KW - Drug discontinuation

KW - Long-term effect

KW - Prolonged symptomatic benefit

KW - Varenicline

M3 - Chapter

BT - Proceedings of the World Congress on Parkinson’s Disease and Related Disorders

ER -